First-to-Market vs. Most-Efficient-to-Market: Why Speed Alone Loses the Generic Drug Race
Speed sells. Until it doesnt.
For years, the generic-drug race has been framed as a pure sprint: file first, win first, capture share before competitors arrive. But the most important shift in the generics economy is already underwaybecause first to ma…
